Cargando…
Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer
As a well-known anticancer drug, paclitaxel (PTX), a first-line chemotherapeutic agent, remains unsatisfactory for gastric cancer therapy. It is reported that triptolide (TPL) could enhance the anti-gastric cancer effect of PTX. Considering the poor solubility of both drugs, we developed a red blood...
Autores principales: | Wang, Siwan, Jiang, Hui, Wang, Jia, Wu, Haisi, Wu, Ting, Ni, Mengnan, Zhao, Qianqian, Ji, You, Zhang, Ziting, Tang, Chunming, Xu, Huae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383169/ https://www.ncbi.nlm.nih.gov/pubmed/34421008 http://dx.doi.org/10.7555/JBR.35.20210102 |
Ejemplares similares
-
Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment
por: Zhang, Ziting, et al.
Publicado: (2022) -
Superior antitumor effect of self-assembly supramolecular paclitaxel nanoparticles
por: Yu, Na, et al.
Publicado: (2020) -
Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy
por: Wu, Ting, et al.
Publicado: (2022) -
A biomimetic and pH-sensitive polymeric micelle as carrier for paclitaxel delivery
por: Ma, Boxuan, et al.
Publicado: (2018) -
Transdermal delivery of triptolide–phospholipid complex to treat rheumatoid arthritis
por: Liu, Xin-Yi, et al.
Publicado: (2021)